Ensign Peak Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,581
| Closed | -$220K | – | 2074 |
|
|
2022
Q3 | $220K | Hold |
4,581
| – | – | ﹤0.01% | 1844 |
|
|
2022
Q2 | $261K | Hold |
4,581
| – | – | ﹤0.01% | 1716 |
|
|
2022
Q1 | $370K | Hold |
4,581
| – | – | ﹤0.01% | 1676 |
|
|
2021
Q4 | $928K | Sell |
4,581
-5,386
| -54% | -$1.09M | ﹤0.01% | 1332 |
|
|
2021
Q3 | $2.69M | Hold |
9,967
| – | – | 0.01% | 946 |
|
|
2021
Q2 | $2.57M | Hold |
9,967
| – | – | 0.01% | 978 |
|
|
2021
Q1 | $2.99M | Hold |
9,967
| – | – | 0.01% | 863 |
|
|
2020
Q4 | $2.54M | Hold |
9,967
| – | – | 0.01% | 931 |
|
|
2020
Q3 | $2.48M | Hold |
9,967
| – | – | 0.01% | 851 |
|
|
2020
Q2 | $3.46M | Hold |
9,967
| – | – | 0.01% | 720 |
|
|
2020
Q1 | $2.67M | Hold |
9,967
| – | – | 0.01% | 712 |
|
|
2019
Q4 | $3.23M | Buy |
+9,967
| New | +$3.23M | 0.01% | 813 |
|